(19)
(11) EP 4 003 005 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
13.12.2023 Bulletin 2023/50

(45) Mention of the grant of the patent:
02.08.2023 Bulletin 2023/31

(21) Application number: 20750361.6

(22) Date of filing: 17.07.2020
(51) International Patent Classification (IPC): 
A01N 1/02(2006.01)
A61B 17/00(2006.01)
A61F 2/06(2013.01)
(52) Cooperative Patent Classification (CPC):
A01N 1/0242; A61F 2/062; A61B 17/00008
(86) International application number:
PCT/IB2020/056750
(87) International publication number:
WO 2021/014312 (28.01.2021 Gazette 2021/04)

(54)

CONDITIONING DEVICE FOR CONDITIONING AN EXPOSED STRETCH OF A BLOOD VESSEL

KONDITIONIERVORRICHTUNG ZUM KONDITIONIEREN EINES EXPONIERTEN ABSCHNITTS EINES BLUTGEFÄSSES

DISPOSITIF DE CONDITIONNEMENT PERMETTANT DE CONDITIONNER UNE SECTION EXPOSÉE D'UN VAISSEAU SANGUIN


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 22.07.2019 IT 201900012537

(43) Date of publication of application:
01.06.2022 Bulletin 2022/22

(73) Proprietors:
  • Politecnico di Milano
    20133 Milano (MI) (IT)
  • Centro Cardiologico Monzino S.p.A.
    20121 Milano (IT)
  • Universita' degli Studi di Milano
    20122 Milano (IT)

(72) Inventors:
  • FIORE, Gianfranco Beniamino
    20133 Milano (IT)
  • SONCINI, Monica
    20133 Milano (IT)
  • PIOLA, Marco
    20133 Milano (IT)
  • PESCE, Maurizio
    20121 Milano (IT)
  • AGRIFOGLIO, Marco
    20122 Milano (IT)

(74) Representative: Crippa, Paolo Ernesto et al
Jacobacci & Partners S.p.A. Via Senato, 8
20121 Milano
20121 Milano (IT)


(56) References cited: : 
WO-A2-98/20027
US-B2- 9 579 224
   
  • JOYCE CHEUNG-FLYNN ET AL: "Limiting Injury During Saphenous Vein Graft Preparation For Coronary Arterial Bypass Prevents Metabolic Decompensation", SCIENTIFIC REPORTS, vol. 7, no. 14179, 27 October 2017 (2017-10-27), XP055686699, DOI: 10.1038/s41598-017-13819-w
  • PETER LAMM ET AL: "Continuous graft perfusion: Optimizing the quality of saphenous vein grafts", HEART SURGERY FORUM, vol. 5, no. Suppl 4, 1 February 2002 (2002-02-01), pages S355-S361, XP055687018,
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).